Financial statements Apipharma Bis
Balance sheet of Apipharma Bis
Share capital:
Share capital:
5 000 PLN
Company deleted from KRS: 2024-02-15
Balance sheet data of APIPHARMA BIS
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
|---|---|---|---|---|---|
| Total assets | 2 406,57 | 4 765,07 | 7 082,57 | 4 081,57 | 2 946,57 |
| A. Fixed assets | 748,00 | 195,00 | 459,00 | 755,00 | 577,00 |
| B. Current assets | 1 658,57 | 4 570,07 | 6 623,57 | 3 326,57 | 2 369,57 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 2 406,57 | 4 765,07 | 7 082,57 | 4 081,57 | 2 946,57 |
| A. Equity | 2 209,64 | 4 509,07 | 6 826,57 | 3 835,57 | 2 700,57 |
| B. Liabilities and provisions for liabilities | 196,93 | 256,00 | 256,00 | 246,00 | 246,00 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 196,93 | 256,00 | 256,00 | 246,00 | 246,00 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.